Georges Köhler Prize for Sebastian Kobold
Enlarge Professor Sebastian Kobold | © LMU KlinikumThe research award is aimed at outstanding scientists under the age of 40 who have made a contribution to our understanding of the immune system and associated practical applications.
Named after Nobel Prize winner Georges Jean Franz Köhler, the award comes with a cash prize of 3,000 euros.
Sebastian Kobold, Professor of Experimental Immuno-Oncology at LMU and Deputy Director of the Clinical Pharmacology Department at the University of Munich Hospital, received the prize for his work on tumor immunology with a special focus on cellular and antibody-delivered therapies.
Kobold’s key fields of research are the interactions between cancer cells and their environment as the driver of tumor advancement and the development of innovative (immune) cell-based therapeutics.
“Given my French and German heritage, it is a special honor for me,” says Kobold, “to receive this highest of scientific accolades from our immunology society at their very first joint annual congress with the French Society for Immunology.”
Professor Sebastian Kobold | © LMU Klinikum
The research award is aimed at outstanding scientists under the age of 40 who have made a contribution to our understanding of the immune system and associated practical applications. Named after Nobel Prize winner Georges Jean Franz Köhler, the award comes with a cash prize of 3,000 euros.
Sebastian Kobold, Professor of Experimental Immuno-Oncology at LMU and Deputy Director of the Clinical Pharmacology Department at the University of Munich Hospital, received the prize for his work on tumor immunology with a special focus on cellular and antibody-delivered therapies. Kobold’s key fields of research are the interactions between cancer cells and their environment as the driver of tumor advancement and the development of innovative (immune) cell-based therapeutics.
“Given my French and German heritage, it is a special honor for me,” says Kobold, “to receive this highest of scientific accolades from our immunology society at their very first joint annual congress with the French Society for Immunology.”
